TTM
$2.90B
YoY change
+30.7%
5Y CAGR
+24.5%
Peak year (2025)
$2.71B
Cumulative revenue
$14.06B
Revenue history chart for Insulet (PODD) from 2002 to 2025
Latest: $2.71B
Revenue growth chart for Insulet (PODD) from 2002 to 2025
Latest: +30.7%
Revenue history table for Insulet (PODD) from 2002 to 2025
| 2025 | $2.71B | +30.7% | +$636.50M | ||
| 2024 | $2.07B | +22.1% | +$374.50M | ||
| 2023 | $1.70B | +30.0% | +$391.80M | ||
| 2022 | $1.31B | +18.8% | +$206.50M | ||
| 2021 | $1.10B | +21.5% | +$194.40M | ||
| 2020 | $904.40M | +22.5% | +$166.20M | ||
| 2019 | $738.20M | +30.9% | +$174.38M | ||
| 2018 | $563.82M | +21.6% | +$100.06M | ||
| 2017 | $463.77M | +26.4% | +$96.78M | ||
| 2016 | $366.99M | +39.1% | +$103.10M | ||
| 2015 | $263.89M | -8.6% | −$24.83M | ||
| 2014 | $288.72M | +16.9% | +$41.64M | ||
| 2013 | $247.08M | +16.9% | +$35.72M | ||
| 2012 | $211.37M | +38.8% | +$59.11M | ||
| 2011 | $152.25M | +57.0% | +$55.29M | ||
| 2010 | $96.97M | +46.8% | +$30.93M | ||
| 2009 | $66.03M | +83.1% | +$29.97M | ||
| 2008 | $36.06M | +169.7% | +$22.69M | ||
| 2007 | $13.37M | +265.1% | +$9.71M | ||
| 2006 | $3.66M | +7226.0% | +$3.61M | ||
| 2005 | $50.00K | — | +$50.00K | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | — |
- 2025$2.71B+30.7%
- 2024$2.07B+22.1%
- 2023$1.70B+30.0%
- 2022$1.31B+18.8%
- 2021$1.10B+21.5%
- 2020$904.40M+22.5%
- 2019$738.20M+30.9%
- 2018$563.82M+21.6%
- 2017$463.77M+26.4%
- 2016$366.99M+39.1%
- 2015$263.89M-8.6%
- 2014$288.72M+16.9%
- 2013$247.08M+16.9%
- 2012$211.37M+38.8%
- 2011$152.25M+57.0%
- 2010$96.97M+46.8%
- 2009$66.03M+83.1%
- 2008$36.06M+169.7%
- 2007$13.37M+265.1%
- 2006$3.66M+7226.0%
- 2005$50.00K—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
Revenue values are taken from Insulet's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Insulet (PODD)
According to Insulet's latest reported financial statements, the company's current revenue (TTM) is $2.90B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Insulet (PODD) revenue totalled $2.71B – surged 30.7% year-over-year.
Insulet revenue has grown for 10 consecutive years, with a +24.5% compound annual growth rate over 2020–2025 (5 years).
The record annual revenue stands at $2.71B, reached in 2025; the historical low of $0.00 was recorded in 2002.
Insulet Revenue by Year
Insulet Revenue 2025: $2.71B
In 2025, Insulet reported revenue of $2.71B, surged 30.7% from 2024. This figure represents the highest annual value in the available history.
Insulet Revenue 2024: $2.07B
Insulet revenue in 2024 was $2.07B, grew 22.1% from 2023.
Insulet Revenue 2023: $1.70B
2023's revenue for Insulet came in at $1.70B, surged 30.0% from 2022.
Insulet Revenue 2022: $1.31B
Insulet posted revenue of $1.31B in 2022, grew 18.8% from 2021.
Insulet Revenue 2021: $1.10B
Insulet revenue in 2021 was $1.10B.
See more financial history for Insulet (PODD).
Sector peers by Revenue
Healthcare peers of Insulet (PODD), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Insulet (PODD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation